Nova Molecular Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Private

  • Employees
  • 57

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

Nova Molecular General Information

Description

Manufacturer of industrial chemical products intended to create sustainable supply chain systems used in agriculture, biotechnology, contract development, and manufacturing organizations The company offers solvents, tetrahydrofuran, tetrahydrofurfuryl alcohol, gas treatment chemicals, sulfolane, nitroxyls, amines, enabling chemical industry with savings in addition to reducing environmental impact and risk mitigation of raw material supply.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Industrial Chemicals
Other Industries
Specialty Chemicals
Corporate Office
  • IronTek Building
  • 635 3rd Street
  • Beloit, WI 53511
  • United States
+1 (608) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nova Molecular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC Completed Generating Revenue
To view Nova Molecular’s complete valuation and funding history, request access »

Nova Molecular Patents

Nova Molecular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-7132540-B1 Such as 1,5-dioxa-9-aza-8,8,10,10-tetramethylspiro[5,5]undec-9-yloxy, useful for the inhibition of polymerization Inactive 30-Apr-2001 0000000000 0
US-6331648-B1 Ether amines and derivatives Inactive 13-Dec-1999 0000000000 0
US-6114585-A A chemical intermediates for hydrogenated to yield a polyamine Inactive 13-Dec-1999 0000000000 0
US-6417401-B1 Alkoxylated tertiary ether diamine oxide; nonionic surfactants, detergents, emulsifiers Inactive 13-Dec-1999 0000000000 0
US-6426436-B1 Tertiary amines made by the reaction of ether diamine compounds with ethylenee, propylene or butylene oxides or mixtures, or with formaldehyde and hydrogen Inactive 13-Dec-1999 C07C217/08 0
To view Nova Molecular’s complete patent history, request access »

Nova Molecular Executive Team (4)

Name Title Board Seat Contact Info
Christopher Adams Chief Executive Officer & President
Steve Hoeppner Chief Financial Officer
Mike Clumpner Founder & Chairman
You’re viewing 3 of 4 executive team members. Get the full list »

Nova Molecular Board Members (3)

Name Representing Role Since
Mike Clumpner Nova Molecular Founder & Chairman 000 0000
Tyler Ellison Self Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Nova Molecular Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nova Molecular Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mission BioCapital Venture Capital Minority 000 0000 000000 0
To view Nova Molecular’s complete investors history, request access »

Nova Molecular FAQs

  • When was Nova Molecular founded?

    Nova Molecular was founded in 1991.

  • Who is the founder of Nova Molecular?

    Mike Clumpner is the founder of Nova Molecular.

  • Who is the CEO of Nova Molecular?

    Christopher Adams is the CEO of Nova Molecular.

  • Where is Nova Molecular headquartered?

    Nova Molecular is headquartered in Beloit, WI.

  • What is the size of Nova Molecular?

    Nova Molecular has 57 total employees.

  • What industry is Nova Molecular in?

    Nova Molecular’s primary industry is Industrial Chemicals.

  • Is Nova Molecular a private or public company?

    Nova Molecular is a Private company.

  • What is Nova Molecular’s current revenue?

    The current revenue for Nova Molecular is 000000.

  • Who are Nova Molecular’s investors?

    Mission BioCapital has invested in Nova Molecular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »